MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load

被引:30
|
作者
Janes, Holly [1 ,2 ]
Frahm, Nicole [1 ,3 ]
DeCamp, Allan [1 ]
Rolland, Morgane [4 ]
Gabriel, Erin [2 ]
Wolfson, Julian [5 ]
Hertz, Tomer [1 ]
Kallas, Esper [6 ]
Goepfert, Paul [7 ]
Friedrich, David P. [1 ]
Corey, Lawrence [1 ,8 ]
Mullins, James I. [9 ]
McElrath, M. Juliana [1 ,8 ]
Gilbert, Peter [1 ,2 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Div Vaccines & Infect Dis, Seattle, WA 98104 USA
[2] Univ Washington, Dept Biostat, Seattle, WA 98195 USA
[3] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA
[4] US Mil HIV Res Program MHRP, Rockville, MD USA
[5] Univ Minnesota, Div Biostat, Minneapolis, MN USA
[6] Univ Sao Paulo, Div Clin Immunol & Allergy, Sao Paulo, Brazil
[7] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA
[8] Univ Washington, Dept Med, Seattle, WA USA
[9] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA
来源
PLOS ONE | 2012年 / 7卷 / 08期
关键词
FALSE DISCOVERY RATE; MEDIATED-IMMUNITY; STEP; GAG; EPITOPES; ESCAPE; CTL;
D O I
10.1371/journal.pone.0043396
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: The sieve analysis for the Step trial found evidence that breakthrough HIV-1 sequences for MRKAd5/HIV-1 Gag/Pol/Nef vaccine recipients were more divergent from the vaccine insert than placebo sequences in regions with predicted epitopes. We linked the viral sequence data with immune response and acute viral load data to explore mechanisms for and consequences of the observed sieve effect. Methods: Ninety-one male participants (37 placebo and 54 vaccine recipients) were included; viral sequences were obtained at the time of HIV-1 diagnosis. T-cell responses were measured 4 weeks post-second vaccination and at the first or second week post-diagnosis. Acute viral load was obtained at RNA-positive and antibody-negative visits. Findings: Vaccine recipients had a greater magnitude of post-infection CD8+ T cell response than placebo recipients (median 1.68% vs 1.18%; p = 0.04) and greater breadth of post-infection response (median 4.5 vs 2; p = 0.06). Viral sequences for vaccine recipients were marginally more divergent from the insert than placebo sequences in regions of Nef targeted by pre-infection immune responses (p = 0.04; Pol p = 0.13; Gag p = 0.89). Magnitude and breadth of pre-infection responses did not correlate with distance of the viral sequence to the insert (p. 0.50). Acute log viral load trended lower in vaccine versus placebo recipients (estimated mean 4.7 vs 5.1) but the difference was not significant (p = 0.27). Neither was acute viral load associated with distance of the viral sequence to the insert (p>0.30). Interpretation: Despite evidence of anamnestic responses, the sieve effect was not well explained by available measures of T-cell immunogenicity. Sequence divergence from the vaccine was not significantly associated with acute viral load. While point estimates suggested weak vaccine suppression of viral load, the result was not significant and more viral load data would be needed to detect suppression.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Host Genetic Determinants of T Cell Responses to the MRKAd5 HIV-1 gag/pol/nef Vaccine in the Step Trial
    Fellay, Jacques
    Frahm, Nicole
    Shianna, Kevin V.
    Cirulli, Elizabeth T.
    Casimiro, Danilo R.
    Robertson, Michael N.
    Haynes, Barton F.
    Geraghty, Daniel E.
    McElrath, M. Juliana
    Goldstein, David B.
    JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (06): : 773 - 779
  • [2] A genome-wide association study of host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the STEP trial
    Fellay, J.
    Shianna, K. V.
    Cirulli, E. T.
    McElrath, J.
    Casimiro, D. R.
    Geraghty, D. E.
    Frahm, N.
    Goldstein, D. B.
    RETROVIROLOGY, 2009, 6
  • [3] Predictors of HVTN 503 MRK AD5 HIV-1 Gag/Pol/Nef Vaccine-Induced Immune Response
    Cerwensky, K.
    Laher, F.
    Otwombe, K.
    Churchyard, G.
    Bekker, L.
    Nchabeleng, M.
    Mlisana, K.
    Kublin, J.
    Gray, G.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (11) : A88 - A88
  • [4] Improvement of the immunogenicity of a HIV-1 clade C candidate vaccine increasing Gag, Pol, Nef and Env specific T-cell responses
    Wild, J.
    Koestler, J.
    Bredl, S.
    Boeckl, K.
    Wagner, R.
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 : 17 - 17
  • [5] P08-06 LB. A genome-wide association study of host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the STEP trial
    J Fellay
    KV Shianna
    ET Cirulli
    J McElrath
    DR Casimiro
    DE Geraghty
    N Frahm
    DB Goldstein
    Retrovirology, 6
  • [6] Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef Vaccine Induced Immune Responses
    Hopkins, Kathryn L.
    Laher, Fatima
    Otwombe, Kennedy
    Churchyard, Gavin
    Bekker, Linda-Gail
    DeRosa, Stephen
    Nchabeleng, Maphoshane
    Mlisana, Koleka
    Kublin, James
    Gray, Glenda
    PLOS ONE, 2014, 9 (08):
  • [7] Human immunodeficiency virus type 1 (HIV-1) vaccine-induced T-cell memory and cytotoxic T-cell (CTL) responses in HIV-1 uninfected volunteers
    Gorse, GJ
    Patel, G
    Mandava, M
    Belshe, R
    CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) : 222 - 222
  • [8] HIV-1 vaccine design based on human vaccine trials to improve Gag, Pol, Nef and Env specific immune responses
    Wild, J.
    Kostler, J.
    Bredl, S.
    Bockl, K.
    Kindsmueller, K.
    Wagner, R.
    RETROVIROLOGY, 2009, 6
  • [9] HIV-1 Vaccine-Induced T-Cell Reponses Cluster in Epitope Hotspots that Differ from Those Induced in Natural Infection with HIV-1
    Hertz, Tomer
    Ahmed, Hasan
    Friedrich, David P.
    Casimiro, Danilo R.
    Self, Steven G.
    Corey, Lawrence
    McElrath, M. Juliana
    Buchbinder, Susan
    Horton, Helen
    Frahm, Nicole
    Robertson, Michael N.
    Graham, Barney S.
    Gilbert, Peter
    PLOS PATHOGENS, 2013, 9 (06)
  • [10] Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults
    Nicholson, Ouzama
    DiCandilo, Fay
    Kublin, James
    Sun, Xiao
    Quirk, Erin
    Miller, Michelle
    Gray, Glenda
    Pape, Jean
    Robertson, Michael N.
    Mehrotra, Devan V.
    Self, Steven
    Turner, Katherine
    Sanchez, Jorge
    Pitisuttithum, Punnee
    Duerr, Ann
    Dubey, Sheri
    Kierstead, Lisa
    Casimiro, Danilo
    Hammer, Scott M.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2011, 27 (05) : 557 - 567